EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 76 filers reported holding EPIZYME INC in Q1 2014. The put-call ratio across all filers is 6.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $91,130,000 | -82.6% | 61,993 | -86.4% | 0.00% | -100.0% |
Q1 2022 | $523,809,000 | -56.6% | 455,486 | -5.7% | 0.00% | -50.0% |
Q4 2021 | $1,206,985,000 | +1339.1% | 482,794 | +2847.3% | 0.00% | – |
Q3 2021 | $83,871,000 | +194.4% | 16,381 | +377.9% | 0.00% | – |
Q2 2021 | $28,487,000 | -87.3% | 3,428 | -86.7% | 0.00% | – |
Q1 2021 | $224,222,000 | +88.9% | 25,743 | +135.5% | 0.00% | – |
Q4 2020 | $118,700,000 | -52.3% | 10,930 | -47.6% | 0.00% | – |
Q3 2020 | $248,752,000 | +51.5% | 20,851 | +104.0% | 0.00% | – |
Q2 2020 | $164,149,000 | -69.1% | 10,221 | -70.2% | 0.00% | -100.0% |
Q1 2020 | $531,590,000 | +97.1% | 34,274 | +212.7% | 0.00% | – |
Q4 2019 | $269,641,000 | +90.5% | 10,961 | -20.1% | 0.00% | – |
Q3 2019 | $141,553,000 | +33.7% | 13,723 | +62.6% | 0.00% | – |
Q2 2019 | $105,909,000 | -37.3% | 8,439 | -38.1% | 0.00% | – |
Q1 2019 | $168,839,000 | +2097.9% | 13,627 | +992.8% | 0.00% | – |
Q4 2018 | $7,682,000 | -76.0% | 1,247 | -58.8% | 0.00% | – |
Q3 2018 | $32,065,000 | -15.4% | 3,025 | +8.2% | 0.00% | – |
Q2 2018 | $37,899,000 | -78.8% | 2,797 | -72.3% | 0.00% | – |
Q1 2018 | $179,062,000 | +41.7% | 10,088 | +0.2% | 0.00% | – |
Q4 2017 | $126,404,000 | +30.7% | 10,072 | +98.4% | 0.00% | – |
Q3 2017 | $96,698,000 | +23.1% | 5,076 | -2.4% | 0.00% | – |
Q2 2017 | $78,550,000 | +411.2% | 5,202 | +480.6% | 0.00% | – |
Q1 2017 | $15,366,000 | -56.1% | 896 | -69.0% | 0.00% | – |
Q4 2016 | $35,005,000 | +7.1% | 2,893 | -12.9% | 0.00% | – |
Q3 2016 | $32,688,000 | +95.4% | 3,322 | +103.3% | 0.00% | – |
Q2 2016 | $16,732,000 | -82.8% | 1,634 | -73.1% | 0.00% | – |
Q4 2015 | $97,178,000 | +21.6% | 6,066 | -2.4% | 0.00% | – |
Q3 2015 | $79,938,000 | +37.8% | 6,216 | +157.2% | 0.00% | – |
Q2 2015 | $58,008,000 | +933.1% | 2,417 | +708.4% | 0.00% | – |
Q1 2015 | $5,615,000 | -69.2% | 299 | -55.5% | 0.00% | – |
Q3 2014 | $18,218,000 | +282.7% | 672 | +339.2% | 0.00% | – |
Q2 2014 | $4,761,000 | +269.9% | 153 | +159.3% | 0.00% | – |
Q1 2014 | $1,287,000 | +93.2% | 59 | +84.4% | 0.00% | – |
Q4 2013 | $666,000 | – | 32 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |